Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and tDCS for Inhibitory Control in ADHD
NCT04964427Completed
- Start
- Feb 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial in attention deficit hyperactivity disorder (ADHD). Primary endpoint: Change in response inhibition measures (Stop Signal Task). Started Feb 2021; status: completed.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04964427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964427.